Insights into the Global Deep Vein Thrombosis (DVT) Market (2018 to 2026) - Opportunity Analysis for New Entrants - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Deep Vein Thrombosis (DVT) Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering.

The Global Deep Vein Thrombosis (DVT) Market is poised to grow at a CAGR of around 10.5% over the next decade during 2018 to 2026.

Deep vein thrombosis (DVT) is the blood clot that develops in the deep veins of the body. It typically occurs in the lower leg, but it can occur in other body parts too. It results in severe leg pain or swelling and shortness of breath. Sometimes, it occurs without symptoms too.

Factors such as the increasing prevalence of obesity, change in lifestyle of people across the globe, and the rising ageing population are driving the market growth. Though, lack of patient education restrains the market growth. Moreover, advancements in the field of healthcare and increasing government initiatives are the opportunities for the deep vein thrombosis (DVT) market.

Based on treatment, the clot buster segment is going to have a lucrative growth during the forecast period. It is used to break-up the clot that is causing a blockage or disruption in the flow of blood to the brain and helps restore the blood flow to the area of the brain. It is given by intravenous (IV), not by mouth.

The key vendors mentioned are Abbott Laboratories, Johnson & Johnson, Merck & Co, Pfizer, Astellas Pharma, Bristol-Myers Squibb, Daiichi Sankyo, Sanofi-Aventis, Boehringer Ingelheim, GSK, and Bayer.

Key Questions Answered in this Report:

• How this market evolved since the year 2016
• Market size estimations, forecasts and CAGR for all the segments presented in the scope
• Key Market Developments and financials of the key players
• Opportunity Analysis for the new entrants
• SWOT Analysis of the key players
• Fastest growing markets analysed during the forecast period
  

Key Topics Covered:

1 Market Synopsis

2 Research Outline

3 Market Dynamics

3.1 Drivers

3.2 Restraints

4 Market Environment

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Deep Vein Thrombosis (DVT) Market, By Treatment

5.1 Introduction

5.2 Inferior Vena Cava Filters

5.3 Compression Stockings

5.4 Clot Busters

5.5 Blood Thinners

5.6 Tissue Plasminogen Activators

6 Global Deep Vein Thrombosis (DVT) Market, By Distribution Channel

6.1 Introduction

6.2 Hospital Pharmacy

6.3 Retail Pharmacy

6.4 E-Commerce

7 Global Deep Vein Thrombosis (DVT) Market, By Status

7.1 Introduction

7.2 Suspended

7.3 Ongoing

7.4 Withdrawn

7.5 Terminated

7.6 Completed

8 Global Deep Vein Thrombosis (DVT) Market, By Type

8.1 Introduction

8.2 Below the Knee

8.3 Above the Knee

9 Global Deep Vein Thrombosis (DVT) Market, By Phase

9.1 Introduction

9.2 Phase I

9.3 Phase II

9.4 Phase III

10 Global Deep Vein Thrombosis (DVT) Market, By Application

10.1 Introduction

10.2 Stockings, Walking, and Repeat Imaging

10.3 Anticoagulation

10.4 IVC Filters, Thrombolysis, and Thrombectomy

11 Global Deep Vein Thrombosis (DVT) Market, By Geography

11.1 North America

11.2 Europe

11.3 Asia Pacific

11.4 South America

11.5 Middle East & Africa

12 Strategic Benchmarking

13 Vendors Landscape

13.1 Abbott Laboratories

13.2 Johnson & Johnson

13.3 Merck & Co

13.4 Pfizer

13.5 Astellas Pharma

13.6 Bristol-Myers Squibb

13.7 Daiichi Sankyo

13.8 Sanofi-Aventis

13.9 Boehringer Ingelheim

13.10 GSK

13.11 Bayer

For more information about this report visit https://www.researchandmarkets.com/r/k3oudh